Ovation Science Inc. (CSE:OVAT)

Market Cap	1.06M
Revenue (ttm)	113.22K
Net Income (ttm)	-456.20K
Shares Out	35.24M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,000
Average Volume	1,800
Open	0.0300
Previous Close	0.0300
Day's Range	0.0300 - 0.0300
52-Week Range	0.0100 - 0.0800
Beta	0.44
RSI	31.56
Earnings Date	May 1, 2025

About Ovation Science

Ovation Science Inc. engages in the production, sub-licensing, and sale of cannabis or hemp products in Canada and the United States. The company sublicenses product formulations through Invisicare, a patented drug delivery technology to produce topical and transdermal cannabis products under the Ovation name. It also offers cannabidiol health and wellness solutions under the Invibe MD name; skincare solutions under the ARLO CBD name; and topical and transdermal creams and lotions with CBD, THC, and combinations, as well as hemp seed oil. Ovati...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2017
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: OVAT

Financial Performance

In 2024, Ovation Science's revenue was 113,215, an increase of 82.80% compared to the previous year's 61,934. Losses were -456,197, -43.90% less than in 2023.